General Information of Drug (ID: DMTNUA4)

Drug Name
ZL-1201
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Antibody
Cross-matching ID
TTD ID
DY7D9A

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Leukocyte surface antigen CD47 (CD47) TT28S46 CD47_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04257617) A Trial of ZL-1201 in Subjects With Advanced Cancer. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of ZAI Lab.